Your browser doesn't support javascript.
loading
Determining the impact of timing and of clinical factors during end-of-life decision-making in potential controlled donation after circulatory death donors.
Kotsopoulos, Angela M; Jansen, Nichon E; Vos, Piet; Witjes, Marloes; Volbeda, Meint; Epker, Jelle L; Sonneveld, Hans P C; Simons, Koen S; Bronkhorst, Ewald M; van der Hoeven, Hans G; Abdo, Wilson F.
Affiliation
  • Kotsopoulos AM; Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Jansen NE; The Dutch Transplant Foundation, Leiden, The Netherlands.
  • Vos P; Department of Intensive Care, Elisabeth TweeSteden Hospital, Tilburg, The Netherlands.
  • Witjes M; Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Volbeda M; Department of Intensive Care Medicine, UMCG University Medical Center, Groningen, The Netherlands.
  • Epker JL; Department of Intensive Care Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Sonneveld HPC; Department of Intensive Care Medicine, Isala Hospital, Zwolle, The Netherlands.
  • Simons KS; Department of Intensive Care Medicine, Jeroen Bosch Hospital, Den Bosch, The Netherlands.
  • Bronkhorst EM; Department of Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van der Hoeven HG; Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Abdo WF; Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Am J Transplant ; 20(12): 3574-3581, 2020 12.
Article in En | MEDLINE | ID: mdl-32506559
Controlled donation after circulatory death (cDCD) occurs after a decision to withdraw life-sustaining treatment and subsequent family approach and approval for donation. We currently lack data on factors that impact the decision-making process on withdraw life-sustaining treatment and whether time from admission to family approach, influences family consent rates. Such insights could be important in improving the clinical practice of potential cDCD donors. In a prospective multicenter observational study, we evaluated the impact of timing and of the clinical factors during the end-of-life decision-making process in potential cDCD donors. Characteristics and medication use of 409 potential cDCD donors admitted to the intensive care units (ICUs) were assessed. End-of-life decision-making was made after a mean time of 97 hours after ICU admission and mostly during the day. Intracranial hemorrhage or ischemic stroke and a high APACHE IV score were associated with a short decision-making process. Preserved brainstem reflexes, high Glasgow Coma Scale scores, or cerebral infections were associated with longer time to decision-making. Our data also suggest that the organ donation request could be made shortly after the decision to stop active treatment and consent rates were not influenced by daytime or nighttime or by the duration of the ICU stay.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Donors / Tissue and Organ Procurement Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am J Transplant Journal subject: TRANSPLANTE Year: 2020 Document type: Article Affiliation country: Netherlands Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Donors / Tissue and Organ Procurement Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am J Transplant Journal subject: TRANSPLANTE Year: 2020 Document type: Article Affiliation country: Netherlands Country of publication: United States